StemTek Therapeutics Private
StemTek Therapeutics is a biopharmaceutical company based in Bilbao, Spain. Their main focus is on the research and development of drugs for cancer treatment. StemTek utilizes stem cell centric point-of-view technologies for cancer therapy, allowing them to profile their pipeline of compounds for their effect on cancer stem cell populations using 3D culture models. Founded by Angel Martin and Olatz Esnaola, StemTek is dedicated to advancing cancer treatment through innovative drug development.
%20.jpg)
Technology:
Regenerative Medicine
Headquarters:
Bilbao, Pais Vasco, Spain
Funding Status:
Seed
Founded Date:
2013-01-01
Last Funding Type:
Seed
Investors Number:
2
Estimated Revenue:
Less than $1M
Employee Number:
10-Jan
Total Funding:
€50K
Industry:
Stem Cells (Regenerative Medicine)
Investor Type:
For Profit